BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37850225)

  • 1. Effect of Mixture of Recombinant Human Bone Morphogenic Protein-2 and Demineralized Bone Matrix in Lateral Lumbar Interbody Fusion.
    Son JI; Lee YS; Ko MJ; Wui SH; Park SW
    J Korean Neurosurg Soc; 2024 May; 67(3):354-363. PubMed ID: 37850225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Study of Radiological and Clinical Outcomes in Patients Undergoing Minimally Invasive Lateral Lumbar Interbody Fusion Using Demineralized Bone Matrix Alone or with Low-Dose Escherichia coli-Derived rhBMP-2.
    Roh YH; Lee JC; Cho HK; Jang HD; Choi SW; Shin BJ
    World Neurosurg; 2022 Feb; 158():e557-e565. PubMed ID: 34775087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, Cost, and Complications of Demineralized Bone Matrix in Instrumented Lumbar Fusion: Comparison With rhBMP-2.
    Eleswarapu A; Rowan FA; Le H; Wick JB; Roberto RF; Javidan Y; Klineberg EO
    Global Spine J; 2021 Oct; 11(8):1223-1229. PubMed ID: 32748702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of ABM/P-15, Bone Morphogenic Protein and Demineralized Bone Matrix after Instrumented Lumbar Interbody Fusion.
    Sathe A; Lee SH; Kim SJ; Eun SS; Choi YS; Lee SM; Seuk JW; Lee YS; Shin SH; Bae J
    J Korean Neurosurg Soc; 2022 Nov; 65(6):825-833. PubMed ID: 35574583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective, Multi-Center, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of the Synthetic Bone Graft Material DBM Gel with rhBMP-2 versus DBM Gel Used during the TLIF Procedure in Patients with Lumbar Disc Disease.
    Hyun SJ; Yoon SH; Kim JH; Oh JK; Lee CH; Shin JJ; Kang J; Ha Y
    J Korean Neurosurg Soc; 2021 Jul; 64(4):562-574. PubMed ID: 33906347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoinductivity and biomechanical assessment of a 3D printed demineralized bone matrix-ceramic composite in a rat spine fusion model.
    Plantz MA; Minardi S; Lyons JG; Greene AC; Ellenbogen DJ; Hallman M; Yamaguchi JT; Jeong S; Yun C; Jakus AE; Blank KR; Havey RM; Muriuki M; Patwardhan AG; Shah RN; Hsu WK; Stock SR; Hsu EL
    Acta Biomater; 2021 Jun; 127():146-158. PubMed ID: 33831576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
    Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of Percutaneous Posterolateral Spinal Fusion With Recombinant Bone Morphogenetic Protein-2 (rhBMP-2): A Comparison With Standard Methods Using an Animal Model Study.
    Chan CY; Kwan MK; Saw LB; Paisal H
    Clin Spine Surg; 2017 Mar; 30(2):E138-E147. PubMed ID: 28207623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy comparison of Accell Evo3 and Grafton demineralized bone matrix putties against autologous bone in a rat posterolateral spine fusion model.
    Brecevich AT; Kiely PD; Yoon BV; Nguyen JT; Cammisa FP; Abjornson C
    Spine J; 2017 Jun; 17(6):855-862. PubMed ID: 28126356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally invasive transforaminal lumbar interbody fusion - A narrative review on the present status.
    Phani Kiran S; Sudhir G
    J Clin Orthop Trauma; 2021 Nov; 22():101592. PubMed ID: 34603954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lateral lumbar interbody fusion - clinical outcomes, fusion rates and complications with recombinant human bone morphogenetic protein-2.
    Morton MB; Wang YY; Buckland AJ; Oehme DA; Malham GM
    Br J Neurosurg; 2023 Apr; ():1-7. PubMed ID: 37029604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
    J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
    Slosar PJ; Josey R; Reynolds J
    Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion.
    Kaiser MG; Groff MW; Watters WC; Ghogawala Z; Mummaneni PV; Dailey AT; Choudhri TF; Eck JC; Sharan A; Wang JC; Dhall SS; Resnick DK
    J Neurosurg Spine; 2014 Jul; 21(1):106-32. PubMed ID: 24980593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD; Kim JY
    J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The local cytokine and growth factor response to recombinant human bone morphogenetic protein-2 (rhBMP-2) after spinal fusion.
    Koerner JD; Markova DZ; Schroeder GD; Calio BP; Shah A; Brooks CW; Vaccaro AR; Anderson DG; Kepler CK
    Spine J; 2018 Aug; 18(8):1424-1433. PubMed ID: 29550606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
    Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmented demineralized bone matrix: a potential alternative for posterolateral lumbar spinal fusion.
    Biswas D; Bible JE; Whang PH; Miller CP; Jaw R; Miller S; Grauer JN
    Am J Orthop (Belle Mead NJ); 2010 Nov; 39(11):531-8. PubMed ID: 21623419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis.
    Martin GJ; Boden SD; Titus L; Scarborough NL
    Spine (Phila Pa 1976); 1999 Apr; 24(7):637-45. PubMed ID: 10209791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.